Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Action of Botox on Urgency in Non-neurogenic Overactive Bladder
2006-000833-36Phase 4Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, single-arm trial of botulinum toxin type A in overactive bladder (OAB), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoint: Change in urgency frequency, warning time, refractory time, and intervoid interval. Started Apr 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2006-000833-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000833-36.